Celsius (NASDAQ:CELH) Given New $90.00 Price Target at Mizuho

Key Points

• Mizuho has raised Celsius's price target from $85.00 to $90.00, indicating a potential upside of 43.13% from its current price, with an "outperform" rating.
• Celsius reported a quarterly EPS of $0.47, surpassing the consensus estimate of $0.23, with revenue increasing by 83.9% year-over-year to $739.30 million.
• Insider selling occurred recently, including CFO Jarrod Langhans who sold 5,000 shares for $300,000, although corporate insiders collectively hold 2.20% of the company's stock.

Celsius (NASDAQ:CELH - Get Free Report) had its price target raised by stock analysts at Mizuho from $85.00 to $90.00 in a report issued on Tuesday,Benzinga reports. The firm currently has an "outperform" rating on the stock. Mizuho's target price would suggest a potential upside of 43.13% from the company's current price.

A number of other research firms have also recently issued reports on CELH. B. Riley restated a "buy" rating and set a $56.00 price target (up from $52.00) on shares of Celsius in a report on Friday, August 8th. Wells Fargo & Company increased their price target on Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a report on Wednesday, June 4th. Needham & Company LLC increased their price target on Celsius from $55.00 to $60.00 and gave the stock a "buy" rating in a report on Thursday, August 7th. UBS Group increased their price target on Celsius from $57.00 to $64.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Finally, Stifel Nicolaus increased their price target on Celsius from $50.00 to $56.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Sixteen investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $55.53.

Celsius Trading Up 5.3%

CELH opened at $62.88 on Tuesday. Celsius has a twelve month low of $21.10 and a twelve month high of $63.50. The company has a quick ratio of 1.76, a current ratio of 2.11 and a debt-to-equity ratio of 0.68. The company has a fifty day moving average of $50.13 and a 200-day moving average of $40.23. The stock has a market cap of $16.22 billion, a PE ratio of 169.95, a price-to-earnings-growth ratio of 1.43 and a beta of 1.33.

Celsius (NASDAQ:CELH - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.23 by $0.24. Celsius had a net margin of 7.91% and a return on equity of 36.88%. The company had revenue of $739.30 million during the quarter, compared to analysts' expectations of $632.13 million. During the same period in the prior year, the company posted $0.28 earnings per share. Celsius's revenue for the quarter was up 83.9% compared to the same quarter last year. On average, sell-side analysts predict that Celsius will post 0.89 EPS for the current year.

Insider Buying and Selling

In related news, CFO Jarrod Langhans sold 5,000 shares of the stock in a transaction on Monday, August 18th. The stock was sold at an average price of $60.00, for a total value of $300,000.00. Following the completion of the sale, the chief financial officer directly owned 104,227 shares of the company's stock, valued at approximately $6,253,620. This represents a 4.58% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, major shareholder William H. Milmoe sold 100,000 shares of the stock in a transaction on Thursday, July 31st. The shares were sold at an average price of $47.50, for a total value of $4,750,000.00. Following the completion of the sale, the insider directly owned 17,717,770 shares of the company's stock, valued at $841,594,075. The trade was a 0.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,116,141 shares of company stock valued at $52,541,605. 2.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Celsius

A number of institutional investors and hedge funds have recently bought and sold shares of CELH. American Assets Inc. purchased a new stake in Celsius in the 4th quarter valued at $1,054,000. The Manufacturers Life Insurance Company increased its position in shares of Celsius by 1.1% during the 4th quarter. The Manufacturers Life Insurance Company now owns 130,894 shares of the company's stock valued at $3,448,000 after purchasing an additional 1,467 shares during the last quarter. Northern Trust Corp increased its position in shares of Celsius by 15.7% during the 4th quarter. Northern Trust Corp now owns 1,347,662 shares of the company's stock valued at $35,497,000 after purchasing an additional 183,163 shares during the last quarter. Triumph Capital Management increased its position in shares of Celsius by 41.5% during the 4th quarter. Triumph Capital Management now owns 40,420 shares of the company's stock valued at $1,065,000 after purchasing an additional 11,863 shares during the last quarter. Finally, Algert Global LLC increased its position in shares of Celsius by 157.8% during the 4th quarter. Algert Global LLC now owns 47,070 shares of the company's stock valued at $1,240,000 after purchasing an additional 28,810 shares during the last quarter. 60.95% of the stock is owned by hedge funds and other institutional investors.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.